Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Vitrafy Life Sciences Ltd. ( (AU:VFY) ) has shared an update.
Vitrafy Life Sciences Limited has announced a change in the indirect interest of its director, John McBain, in the company’s securities. The change involves the acquisition of additional ordinary shares through on-market trades, which reflects a slight increase in McBain’s holdings. This adjustment in director’s interest may indicate a positive outlook or confidence in the company’s future performance, potentially impacting stakeholder perceptions.
The most recent analyst rating on (AU:VFY) stock is a Buy with a A$2.30 price target. To see the full list of analyst forecasts on Vitrafy Life Sciences Ltd. stock, see the AU:VFY Stock Forecast page.
More about Vitrafy Life Sciences Ltd.
Average Trading Volume: 22,454
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$86.2M
See more insights into VFY stock on TipRanks’ Stock Analysis page.